Login to Your Account

Other News To Note

Thursday, February 3, 2011
Metamark Genetics Inc., of Cambridge, Mass., reported that a prostate cancer study published in Nature described the identification of a key tumor suppressor of prostate cancer progression in mice and humans, and revealed four markers that are predictive of biochemical recurrence and lethal metastasis in human prostate cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription